Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Pain × Injections × Clear all

Phase

Phase 4 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 10 Carcinoma, Non-Small-Cell Lung 5 Prostatic Neoplasms 4 Lymphoma, Large B-Cell, Diffuse 4 Stomach Neoplasms 3 Leukemia, Myeloid, Acute 3 Triple Negative Breast Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Recurrence 2 Ovarian Neoplasms 2 Neoplasms 2 Neoplasm Metastasis 2 Multiple Myeloma 2 Lung Neoplasms 2 Disease 2 Carcinoma, Transitional Cell 2 Carcinoma, Hepatocellular 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Thyroid Cancer, Papillary 1 Thrombosis 1 Thrombocytopenia 1 Thoracic Neoplasms 1 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Pituitary Neoplasms 1 Pediatric Solid Tumor, Unspecified, Protocol Specific 1 Papillomavirus Infections 1 Pancreatic Neoplasms 1 Pancreatic Cancer Metastatic 1

Interventions

Fentanyl 7 Zoledronic Acid 6 Radiotherapy 6 Morphine 6 Ibandronic Acid 6 nabiximols 5 Ketamine 5 Hydromorphone 5 Analgesia 5 Tapentadol 4 Oxycodone 4 Acetaminophen 4 alvimopan 3 Ropivacaine 3 Prednisone 3 Lidocaine 3 Acupuncture Therapy 3 cabozantinib 2 Tetrodotoxin 2 Mitoxantrone 2 Gabapentin 2 Docetaxel 2 resiniferatoxin 1 oxycodone-acetaminophen 1 oxycodone naloxone combination 1 ixabepilone 1 Triamcinolone Acetonide 1 Triamcinolone 1 Therapeutics 1 Taxes 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01836328 2016-03-16

RATIOMTD

L'Hospitalet de Llobregat

Phase 3 Completed

Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡